DEUTETRABENAZINE | TEVA | ||
6MG,12MG,18MG,24MG,30MG,36MG,42MG,48MG | |||
No | Yes | ||
2041-Jun-10 | Expired | ||
None | None | ||
None | No | ||
AUSTEDO XR is vesicular monoamine transporter 2 (VMAT2) inhibitors indicated in adults for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
6MG | ** | ** | - | - | - |
12MG | ** | ** | - | - | - |
18MG | ** | ** | - | - | - |
24MG | ** | ** | - | - | - |
30MG | ** | ** | - | - | - |
36MG | ** | ** | - | - | - |
42MG | ** | ** | - | - | - |
48MG | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com